Clinical Trials Directory

Trials / Completed

CompletedNCT04890860

Detection of Right Ventricular Dysfunction by Portal Vein Doppler After Cardiac Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
CMC Ambroise Paré · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Right ventricular (RV) failure after cardiac surgery is associated with morbidity and mortality, but is hard to diagnose with conventional echocardiographic means. RV dysfunction may be associated with hepatic congestion, which may have an effect on portal veinous flow, but this has not been extensively. The investigators aimed determine whether an increased pulsatility in the portal venous flow was associated with RV dysfunction, after cardiac surgery at risk of RV dysfunction: mitral and tricuspid valve procedures.

Detailed description

In cardiac surgical patients, RV dysfunction is associated with organ hypoperfusion and venous congestion leading to increased morbidity and mortality. Non-invasive methods used to assess RV function are 2D-echocardiographic measurement of tricuspid annular plane systolic excursion (TAPSE), RV ejection fraction (EF), RV fractional area change (FAC), 3D assessment of RV function, tissue Doppler assessment of velocities, and magnetic resonance imaging (MRI). Though MRI is the gold standard method to assess RV function, it cannot be used in the perioperative period. In the present prospective observational study, The investigators investigated the association between the pattern of portal venous flow and RV function as assessed by echocardiography in the postoperative period.

Conditions

Interventions

TypeNameDescription
OTHERcardiac surgery involving mitral or tricuspid valve repair procedure, with cardiopulmonary bypasscardiac surgery involving mitral or tricuspid valve repair procedure, with cardiopulmonary bypass

Timeline

Start date
2021-06-15
Primary completion
2022-08-11
Completion
2022-08-11
First posted
2021-05-18
Last updated
2023-03-02

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04890860. Inclusion in this directory is not an endorsement.